REQUEST A DEMO
Total
USD $0.00
Search more companies

"Medycyna Milorzab" Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: "Medycyna Milorzab" Sp. z o.o. Profile Updated: October 14, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

"Medycyna Milorzab" Sp. z o.o is a healthcare company specializing in the diagnosis and treatment of cognitive disorders, particularly Alzheimer's disease and dementia. The company offers psychological therapy, pharmacotherapy, and clinical research projects, utilizing drugs such as cholinesterase and memanthin inhibitors. Their team of specialists provides care for patients of all ages, with a focus on old age psychiatry and neurodegenerative diseases.

Headquarters
Ul. Pl. Pokoju 3/4
Lodz; Lodzkie; Postal Code: 90-227

Contact Details: Purchase the "Medycyna Milorzab" Sp. z o.o. report to view the information.

Website: http://www.medycynamilorzab.pl

Basic Information
Total Employees:
Purchase the "Medycyna Milorzab" Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the "Medycyna Milorzab" Sp. z o.o. report to view the information.
Registered Capital:
Purchase the "Medycyna Milorzab" Sp. z o.o. report to view the information.
Incorporation Date:
April 15, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
51.06%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Purchase this report to view the information.
8.94%
Company Performance
Financial values in the chart are available after "Medycyna Milorzab" Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
24.87%
Total operating revenue
24.79%
Operating profit (EBIT)
N/A
EBITDA
-89.54%
Net Profit (Loss) for the Period
N/A
Total assets
27.62%
Total equity
-0.92%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-1.9%
Cash Ratio
-1.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?